Robert Reich / RobertReich.OrgMar 11, 2018
The recently sentenced businessman's story is tragic and pathetic, but he isn't really different from other figures who dominate American life today. Dig deeper ( 3 Min. Read )
Staff / TruthdigFeb 5, 2016
Embattled Turing Pharmaceuticals CEO Martin Shkreli apparently did not show up for his hearing Thursday before the House Oversight Committee with a mind to shift public opinion in his favor or convince attendant legislators that he held anything resembling respect for the proceedings. Dig deeper ( 2 Min. Read )
Alexander Reed Kelly / TruthdigNov 26, 2015
The disreputable pharmaceutical boss has reneged on an agreement to lower the price of a medication he raised from $13.50 to $750 per pill. Dig deeper ( 1 Min. Read )
Join our newsletterStay up to date with the latest from Truthdig. Join the Truthdig Newsletter for our latest publications.
BLANKSep 27, 2015
The drug company CEO who announced a 5,000 percent increase in the price of a lifesaving drug was forced to back down after Twitter users, the industry and others exploded in outrage. We have three words for these sometimes rude commenters: Good for you. Dig deeper ( 3 Min. Read )
Staff / TruthdigSep 23, 2015
In case you hadn't heard, last month, Turing Pharmaceuticals CEO and former hedge fund manager Martin Shkreli got hold of the rights to parasite-zapping drug Daraprim, and then he had the bright idea to raise the price from $13.50 to $750 per pill. Now he has a big public relations problem and a self-created health care crisis on his hands. Dig deeper ( 1 Min. Read )
Join our newsletterStay up to date with the latest from Truthdig. Join the Truthdig Newsletter for our latest publications.
Now you can personalize your Truthdig experience. To bookmark your favorite articles and follow your favorite authors, please login or create a user profile.
Now you can personalize your Truthdig experience. To bookmark your favorite articles and follow your favorite authors, upgrade to supporter.